ArticleMolecular and cellular biochemistry2026
Inhibiting endoplasmic reticulum stress and unfolded protein response: an effective strategy for chemoprevention of hepatocarcinogenesis.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoplasmic reticulum stress and activation of the unfolded protein response are critical contributors to hepatocarcinogenesis. Targeting these pathways represents a novel strategy for liver cancer prevention. In this study, a hepatocarcinogenesis model was developed by administering Diethylnitrosamine (DEN) (50 mg/kg b.w, i.p) to male Wistar rats. The endogenous chaperone-inducer BIX was administered (0.1 mg/kg, bw, i.p) for the prevention of DEN-induced hepatocarcinogenesis. After 20 weeks of BIX treatment, its effect on tumor growth was assessed in terms of tumor statistics, tumor-dielectric properties and histopathology. The ER-stress inhibition potential of BIX was assessed using UPR-related genes and protein expression. The inflammatory, proliferative and apoptotic markers were assessed using enzyme immunoassay and fluorescent immunohistochemistry. BIX treatment impeded the growth of hepatic tumors, as demonstrated by decreased total number of tumors and tumor multiplicity. Histopathologically, the tumors in the BIX-protected group had lower histological grading as compared to untreated tumors. This was further supported by dielectric assessment of tumors, suggesting suppressed tumor development. BIX treatment significantly decreased the expression of UPR genes (PERK, ATF-6, CHOP) and proteins (p-PERK/PERK), respectively. Further, significantly decreased expression of inflammatory, proliferative and increased apoptotic markers confirmed the effectiveness of BIX in preventing ER stress-induced hepatocarcinogenesis. BIX effectively attenuated UPR activation and impeded tumor growth.
Indexed as
Identifiers
42635924What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.